Nuffield Health and Icon Group agree to establish a new strategic partnership for the delivery of oncology services in the UK

Nuffield Health, the UK’s largest healthcare charity, and Icon Group, Australia’s largest specialist oncology services provider, have agreed a strategic partnership to deliver oncology services in the UK.

Nuffield Health and Icon Group’s ambition for the partnership is driven by the organisations' shared commitment to deliver the highest-quality oncology care and a seamless, best-in-class experience to patients in the UK. The organisations are working to develop the first phase of the partnership, which focuses on the delivery of radiotherapy.

Nuffield Health is the only UK-wide independent hospital provider to have all hospitals rated ‘Good’ or ‘Outstanding’ by UK regulators*. With a mission to deliver the best care possible as close to home as possible, Icon Group is Australia’s largest integrated cancer care provider and has expanded globally into New Zealand, Singapore, Mainland China and Hong Kong.

Wouter Van den Brande, Chief Strategy and Development Officer of Nuffield Health, says: “Icon Group’s clinical expertise, values and investment strategy align closely with ours. We have a shared vision to deliver the best clinical outcomes to as many people as possible.

“We are working in partnership with Icon to explore how, together, we can meet the rising demand for cancer care in the UK. Our initial focus will be on how our patients can benefit from Icon’s world-leading expertise in radiotherapy.” 

Mark Middleton, Icon Group Chief Executive Officer, says: “We're thrilled to partner with Nuffield Health and work together to help tackle the UK’s cancer burden and improve access to radiotherapy across the region.

“Patient-focused and clinician-led, this partnership prioritises personalised treatment plans and access to cutting edge treatments to deliver the highest standards of care and improved outcome for patients.”

Over the coming months, both organisations will work together on the first phase of the partnership and the details will be announced in due course.

Last updated Monday 21 August 2023

First published on Monday 21 August 2023